Azitra

Azitra Goodwill

The Goodwill of Azitra (AZTR) as of Oct 22, 2026 is 246.17 M USD.

Goodwill

246.17 MUSD

Last updated:

Goodwill of Azitra is 2024 246.17 M USD. Goodwill of Azitra was 2023 - USD. It decreases by % lower compared to the previous year.

The Azitra Goodwill history

The Azitra Goodwill history
YEARGoodwillYoY
246.17 MUSD—

Access this data via the Eulerpool API

100,000 free requests/mo · no credit card

Azitra Stock analysis

What does Azitra do? Azitra Inc., based in Branford, Connecticut, is an early-stage biopharmaceutical company focused on developing topical therapies for dermatological conditions. The company utilizes engineered proteins and live biotherapeutic products, leveraging a microbial library of 1,500 bacterial strains and AI-driven screening to create treatments for skin diseases. Its pipeline includes ATR-12 for Netherton syndrome, ATR-04 for papulopustular rash, and ATR-01 for ichthyosis vulgaris, all targeting unmet medical needs in precision dermatology. Listed on June 16, 2023, Azitra operates with a team of 10 employees. Azitra is one of the most popular companies on Eulerpool.

Frequently Asked Questions about Azitra stock

Goodwill of Azitra is 246.17 M USD in 2024.

On Eulerpool you can find the complete historical development of Goodwill Azitra since 2006 – with annual values, charts, and detailed analysis.

Goodwill is the premium paid above fair market value in an acquisition. It represents intangible value such as brand recognition, customer relationships, and intellectual property.

Goodwill's USD is a key factor for investors. Changes in this metric can signal improving or deteriorating fundamentals, directly impacting the stock price. On Eulerpool, you can track Goodwill's Azitra historically and in real time.

Access this data via the Eulerpool API

100,000 free requests/mo · no credit card

Balance Sheet — Azitra

All Key Metrics — Azitra